Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
2.250
+0.130 (6.13%)
At close: Jan 17, 2025, 4:00 PM
2.380
+0.130 (5.77%)
Pre-market: Jan 21, 2025, 8:13 AM EST
Compugen Employees
Compugen had 68 employees as of December 31, 2023. The number of employees decreased by 1 or -1.45% compared to the previous year.
Employees
68
Change (1Y)
-1
Growth (1Y)
-1.45%
Revenue / Employee
$880,176
Profits / Employee
$23,515
Market Cap
201.46M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
CGEN News
- 13 days ago - Compugen Announces First Patient Dosed in Phase 1 Clinical Trial to Evaluate COM503 as Monotherapy and in Combination with Zimberelimab in Advanced Solid Tumors - PRNewsWire
- 7 weeks ago - Compugen Expands its Intellectual Property Portfolio with New U.S. Patent Covering Triple Combination Use of COM902 (reduced Fc anti-TIGIT) with anti-PD-1 and anti-PVRIG Antibodies - PRNewsWire
- 2 months ago - Compugen Ltd. (CGEN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Compugen Reports Third Quarter 2024 Results - PRNewsWire
- 2 months ago - Compugen to Participate in Stifel 2024 Healthcare Conference - PRNewsWire
- 2 months ago - Compugen to Present Anti-Tumor Activity and Safety Data of COM701, COM902 and Pembrolizumab Combination in Patients with Platinum Resistant Ovarian Cancer at SITC 2024 - PRNewsWire
- 3 months ago - Compugen to Release Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - PRNewsWire
- 3 months ago - Compugen to Present New Clinical Data at SITC 2024 - PRNewsWire